---
format:
  revealjs:
    spotlight: true
    touch: true
    controls: true
    pointer: true
    center-title-slide: false
    transition: fade
    transition-speed: fast
    scrollable: true
    slide-number: true
    incremental: false
    multiplex: true
    chalkboard: true
    theme: [default, custom.scss]
    filters:
     - highlight-text
bibliography: references.bib
lightbox: true
csl: diagnostic-microbiology-and-infectious-disease.csl
---

## Lecture 5: β-lactams, Part 2: <br> Cephalosporins and carbapenems {background-image="images/Bronzu.png" background-opacity="0.1"}

<br> <br> <br> <br>

**Russell E. Lewis** <br> Associate Professor of Infectious Diseases <br> Department of Molecular Medicine <br> University of Padua

<br> {{< fa solid envelope size=1x >}} russelledward.lewis\@unipd.it <br> {{< fa brands github size=1x >}} [https://github.com/Russlewisbo](https://github.com/Russlewisbo/ESCMID_2022_talk)

![](images/University_of_Padua_seal.svg){width="100"}

## Agenda

## Discovery of cephalosporins {.smaller}

<br>

::::: columns
::: {.column width="40%"}
![](images/Bronzu.png){width="800"}
:::

::: {.column width="60%"}
<br>

-   Bronzu performed epidemiological studies of typhoid infection in Cagliari, noted *Salmonella typhi* was not cultured once sewer water was discharged into the sea
-   Isolated the mold *Cephalosporium* (now known as *Acremonium*) in 1948 from seawater
-   Noticed that these cultures produced substances (he named mycetin) that were effective against *Salmonella typhi*, the cause of typhoid fever, which had beta-lactamase.
-   After he failed to find support from Italian government, he sent the fungus to Howard Florey at Oxford
-   1962: Isolation of cephalosporin C
:::
:::::

## First generation cephalosporins; <br> derivatives of 7-ACA {.smaller}

![](images/1gen.png){fig-align="center" width="400"}

::: aside
-   Gram positive activity: Cover Methicillin-sensitive *S. aureus* (MSSA) and streptococci:
-   Used for uncomplicated skin and soft-tissue infections (SSI)
-   Surgical prophylaxis: cefazolin
-   Some Gram negative coverage in urine: *P. mirabilis, E. coli, and K. pneumoniae*
:::

## Pharmacokinetics: 1st generation cephalosporins {.smaller}

<br> <br>

+-------------------+---------------------------------------------------------------------------------------------------------+
| **Absorption**    | Penicillin VK (oral); bioavailibility 60-73% <br> Penicillin G (IV) <br>Benzathine penicillin (IM) <br> |
+-------------------+---------------------------------------------------------------------------------------------------------+
| **Distribution**  | -   0.35 L/kg                                                                                           |
|                   |                                                                                                         |
|                   | -   65% protein bound                                                                                   |
|                   |                                                                                                         |
|                   | -   500% bile:serum                                                                                     |
|                   |                                                                                                         |
|                   | -   5-10% CSF:blood (therapeutic for some pathogens)                                                    |
+-------------------+---------------------------------------------------------------------------------------------------------+
| **Metabolism**    | -   No metabolism                                                                                       |
|                   |                                                                                                         |
|                   | -   t½ 0.5 hr                                                                                           |
|                   |                                                                                                         |
|                   | -   Substrate of OAT transporters                                                                       |
+-------------------+---------------------------------------------------------------------------------------------------------+
| **Elimination**   | Renal 100%, impaired by probenicid                                                                      |
+-------------------+---------------------------------------------------------------------------------------------------------+
| **PK:PD target**  | ≥ 40-50% *f*Time~\>MIC~                                                                                 |
+-------------------+---------------------------------------------------------------------------------------------------------+
| **Typical doses** | (Pen VK) 250-500 mg TID-QID before meals and at bedtime                                                 |
|                   |                                                                                                         |
|                   | (Low dose) 600,000-1.2 MU IM/day                                                                        |
|                   |                                                                                                         |
|                   | (High dose) Penicillin G: \> 20 MU IV daily                                                             |
+-------------------+---------------------------------------------------------------------------------------------------------+

::: aside
Source: Sanford Guide
:::

## References

<br>

<br>
